Welcome to Market Research Explore
MRE

Explore Market Research

Latest market research, industry analysis and market trend reports

Global Drugs For Herpes Labialis (Oral Herpes) Market Analysis 2011-2017 and Forecast 2018-2023

Snapshot Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection. The global Drugs For Herpes Labialis (Oral Herpes) market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs For Herpes Labialis (Oral Herpes) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report. Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.): Valacyclovir Aciclovir Famciclovir Docosanol Others Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.): GSK Novartis Teva Mylan Cadila Apotex Daewoong Pharmaceutical Livzon Luoxin Med shine Bayer (Campho Phenique) Blistex Kelun Group Hikma Haiwang Carmex Cipher Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.): External Use Oral Injection Region Coverage (Regional Output, Demand & Forecast by Countries etc.): North America Europe Asia-Pacific South America Middle East & Africa

Table of Content 1 Industry Overview 1.1 Drugs For Herpes Labialis (Oral Herpes) Industry 1.1.1 Overview 1.1.2 Development of Drugs For Herpes Labialis (Oral Herpes) 1.2 Market Segment 1.2.1 Upstream 1.2.2 Downstream 1.3 Cost Analysis 2 Industry Environment 2.1 Policy 2.2 Economics 2.3 Sociology 2.4 Technology 3 Drugs For Herpes Labialis (Oral Herpes) Market by Type 3.1 Segment Overview 3.1.1 Valacyclovir 3.1.2 Aciclovir 3.1.3 Famciclovir 3.1.4 Docosanol 3.1.5 Others 3.2 Market Size 3.3 Market Forecast 4 Major Companies List 4.1 GSK (Company Profile, Sales Data etc.) 4.2 Novartis (Company Profile, Sales Data etc.) 4.3 Teva (Company Profile, Sales Data etc.) 4.4 Mylan (Company Profile, Sales Data etc.) 4.5 Cadila (Company Profile, Sales Data etc.) 4.6 Apotex (Company Profile, Sales Data etc.) 4.7 Daewoong Pharmaceutical (Company Profile, Sales Data etc.) 4.8 Livzon (Company Profile, Sales Data etc.) 4.9 Luoxin (Company Profile, Sales Data etc.) 4.10 Med shine (Company Profile, Sales Data etc.) 4.11 Bayer (Campho Phenique) (Company Profile, Sales Data etc.) 4.12 Blistex (Company Profile, Sales Data etc.) 4.13 Kelun Group (Company Profile, Sales Data etc.) 4.14 Hikma (Company Profile, Sales Data etc.) 4.15 Haiwang (Company Profile, Sales Data etc.) 4.16 Carmex (Company Profile, Sales Data etc.) 4.17 Cipher (Company Profile, Sales Data etc.) 5 Market Competition 5.1 Company Competition 5.2 Regional Market by Company 6 Market Demand 6.1 Demand Situation 6.1.1 Demand in External Use 6.1.2 Demand in Oral 6.1.3 Demand in Injection 6.2 Regional Demand Comparison 6.3 Demand Forecast 7 Region Operation 7.1 Regional Output 7.2 Regional Market 7.3 by Region 7.3.1 North America 7.3.1.1 Overview 7.3.1.2 by Country (U.S., Canada, Mexico) 7.3.2 Europe 7.3.2.1 Overview 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.) 7.3.3 Asia-Pacific 7.3.3.1 Overview 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.) 7.3.4 South America 7.3.4.1 Overview 7.3.4.2 by Country (Brazil, Argentina etc.) 7.3.5 Middle East & Africa 7.3.5.1 Overview 7.3.5.2 by Country (Saudi Arabia, South Africa etc.) 7.4 Regional Forecast 8 Marketing & Price 8.1 Price and Margin 8.1.1 Price Trends 8.1.2 Factors of Price Change 8.1.3 Manufacturers Gross Margin Analysis 8.2 Value Chain 8.3 Marketing Channel 9 Research Conclusion Table Upstream Segment of Drugs For Herpes Labialis (Oral Herpes) Table Application Segment of Drugs For Herpes Labialis (Oral Herpes) Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2023, by Application, in USD Million Table Major Company List of Valacyclovir Table Major Company List of Aciclovir Table Major Company List of Famciclovir Table Major Company List of Docosanol Table Major Company List of Others Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2017, by Type, in USD Million Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2017, by Type, in Volume Table Global Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2017-2023, by Type, in USD Million Table Global Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2017-2023, by Type, in Volume Table GSK Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Novartis Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Teva Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Mylan Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Cadila Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Cadila (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Apotex Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Apotex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Daewoong Pharmaceutical Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Daewoong Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Livzon Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Livzon (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Luoxin Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Luoxin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Med shine Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Med shine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Bayer (Campho Phenique) Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Bayer (Campho Phenique) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Blistex Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Blistex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Kelun Group Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Kelun Group (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Hikma Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Haiwang Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Haiwang (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Carmex Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Carmex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Cipher Overview List Table Drugs For Herpes Labialis (Oral Herpes) Business Operation of Cipher (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue 2012-2017, by Company, in USD Million Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Revenue Share, by Company, in USD Million Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Volume 2012-2017, by Company, in Volume Table Global Drugs For Herpes Labialis (Oral Herpes) Sales Volume Share 2012-2017, by Company, in Volume Table Drugs For Herpes Labialis (Oral Herpes) Demand in External Use, 2012-2017, in USD Million Table Drugs For Herpes Labialis (Oral Herpes) Demand in External Use, 2012-2017, in Volume Table Major Consumers Profile in External Use Table Drugs For Herpes Labialis (Oral Herpes) Demand in Oral, 2012-2017, in USD Million Table Drugs For Herpes Labialis (Oral Herpes) Demand in Oral, 2012-2017, in Volume Table Major Consumers Profile in Oral Table Drugs For Herpes Labialis (Oral Herpes) Demand in Injection, 2012-2017, in USD Million Table Drugs For Herpes Labialis (Oral Herpes) Demand in Injection, 2012-2017, in Volume Table Major Consumers Profile in Injection Table Regional Demand Comparison List Table Major Application in Different Regions Table Drugs For Herpes Labialis (Oral Herpes) Demand Forecast 2017-2023, by Application, in USD Million Table Drugs For Herpes Labialis (Oral Herpes) Demand Forecast 2017-2023, by Application, in Volume Table Drugs For Herpes Labialis (Oral Herpes) Output 2012-2017, by Region, in USD Million Table Drugs For Herpes Labialis (Oral Herpes) Output 2012-2017, by Region, in Volume Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2017, by Region, in USD Million Table Global Drugs For Herpes Labialis (Oral Herpes) Market Share 2012-2017, by Region, in USD Million Table Global Drugs For Herpes Labialis (Oral Herpes) Market 2012-2017, by Region, in Volume Table Global Drugs For Herpes Labialis (Oral Herpes) Market Share 2012-2017, by Region, in Volume Table North America Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in USD Million Table North America Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in Volume Table Europe Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in USD Million Table Europe Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in Volume Table Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in USD Million Table Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in Volume Table South America Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in USD Million Table South America Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in Volume Table Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in USD Million Table Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size 2012-2017, by Country, in Volume Table Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2017-2023, by Region, in USD Million Table Drugs For Herpes Labialis (Oral Herpes) Market Forecast 2017-2023, by Region, in Volume Table Price Factors List Table Notes of Part Source Table Methodology Introduction Figure Drugs For Herpes Labialis (Oral Herpes) Industry Chain Structure Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Growth 2012-2017, by Type, in USD Million Figure Global Drugs For Herpes Labialis (Oral Herpes) Market Growth 2012-2017, by Type, in Volume Figure North America Drugs For Herpes Labialis (Oral Herpes) Market, by Company, in 2017 Figure Europe Drugs For Herpes Labialis (Oral Herpes) Market Market, by Company, in 2017 Figure Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Market, by Company, in 2017 Figure South America Drugs For Herpes Labialis (Oral Herpes) Market Market, by Company, in 2017 Figure Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Market, by Company, in 2017 Figure North America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in USD Million Figure North America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in Volume Figure Europe Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in USD Million Figure Europe Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in Volume Figure Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in USD Million Figure Asia-Pacific Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in Volume Figure South America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in USD Million Figure South America Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in Volume Figure Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in USD Million Figure Middle East & Africa Drugs For Herpes Labialis (Oral Herpes) Market Size and Growth 2012-2017, in Volume Figure Marketing Channels Overview


  Payment Mode
Single User $ 2980
Corporate User $ 5960

  About this Report
Category Healthcare & Pharmaceuticals
Published on 1/3/2017
Number of Pages 111
Over all Rating
"Rating is based on 86 reviews"